Johnson & Johnson expects full-year earnings in the range of $10.50 to $10.70 per share, with revenue in the range of $91 billion to $91.8 billion. This story was generated by Automated Insights ( ...

Drugmaker Novartis plans to spend $23 billion at 10 of its U.S. facilities, as the pharma industry grapples with Trump’s ...

Products made here might still depend on materials from overseas. And they might be made on machines needing foreign replacement parts.

Meanwhile, Johnson & Johnson, a global drugmaker based in New Brunswick, announced plans in March to spend $55 billion over the next four years on domestic manufacturing, research and technology ...

New Brunswick-based Johnson & Johnson announced plans in March to spend $55 billion over the next four years on domestic manufacturing, research and technology, including a $2 billion North ...

James Wood Johnson and Edward Mead Johnson – founded Johnson & Johnson, in New Brunswick, New Jersey in the United States. It's said that the Johnson brothers were inspired to start the business ...

Singing in spite of their circumstances. Meet Parkinsings: a choir comprised of people battling Parkinson’s disease. Formed ...

Johnson had worked in television and as a bodyguard to celebrities before recently moved to New York City to continue ... the Hudson River in Jersey City, NJ, on April 10, 2025.

New Jersey’s big-name, established life sciences companies include Johnson & Johnson, headquartered in New Brunswick, and Merck ... Cohen pointed to the NJ AI Hub, a partnership of Princeton ...

A 17-year-old and a 16-year-old have been charged with juvenile delinquency offenses related to the fatal shooting of a 16-year-old boy in ...

Health care giant Johnson & Johnson expects about $400 million in tariff-related costs this year. The costs will be felt ...